Turn Therapeutics Inc.

NASDAQ:TTRX

Biotechnology

Healthcare
$8.89 -2.79%

-$0.17 today

Market cap
$271.79M
Beta
2.77
P/E (TTM)
-45.0
EPS (TTM)
-$0.13
52W Low $2.57High $26.50

Volume 0.05M

Average 0.04M

TTRX Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

No reported Net Margin figures are available to summarize.

Net Margin history

Percent of revenue · from the income statement

No Net Margin data reported for this period type.

Net Margin vs competitors

How TTRX compares with its peers on the latest reported figures

TTRX Competitors Peer median
Net Margin for TTRX and competitors
Company Period LTM level YoY 3-year change
AGENAgenus Inc.LTM Mar 202652.2% +243.7 pp+224.6 pp
SEERSeer, Inc.LTM Mar 2026-468.7% +97.4 pp+176.5 pp
IRDOpus Genetics, Inc.LTM Mar 2026-892.4% -462.9 pp-394.2 pp
TTRXTurn Therapeutics Inc.FY2025— ——
GLSIGreenwich LifeSciences, Inc.FY2025— ——
IKTInhibikase Therapeutics, Inc.FY2025— ——
ANIXAnixa Biosciences, Inc.FY2025— ——
HURATuHURA Biosciences, Inc.FY2025— ——
CGTXCognition Therapeutics, Inc.FY2025— ——
Peer median (excluding TTRX) -468.7%+97.4 pp+176.5 pp

Competitors are the stored peer set for TTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue000
Cost of Revenue000
Gross Profit000
Gross Margin———
Research & Development7.5K245.96K265.57K
Selling, General & Admin2.3M1.55M5.59M
Operating Expenses2.31M1.8M5.86M
Depreciation & Amortization43.92K47.48K52.75K
EBITDA(2.25M)(1.72M)(3.14M)
EBITDA Margin———
Operating Income(2.31M)(1.8M)(5.86M)
Operating Margin———
Interest Income15.88K28.71K29.58K
Interest Expense000
Other Income / Expenses15.88K28.71K2.66M
Income Before Tax(2.29M)(1.77M)(3.19M)
Pre-Tax Margin———
Income Tax Expense000
Net Income(2.29M)(1.77M)(3.19M)
Net Margin———
EPS (Basic)(0.17)(0.13)(0.23)
EPS (Diluted)(0.17)(0.13)(0.23)
Weighted Avg Shares13.25M13.42M13.74M
Weighted Avg Shares (Diluted)13.25M13.42M13.74M

Turn Therapeutics Inc.

NASDAQ:TTRX

Intrinsic Alpha fair value

Locked

Current Price

$8.89

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.